These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15356014)

  • 21. Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project.
    Ostgren CJ; Lindblad U; Melander O; Melander A; Groop L; Råstam L
    J Hypertens; 2003 Sep; 21(9):1657-62. PubMed ID: 12923397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
    Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
    Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
    Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
    Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Klupa T; Skupien J; Walus M; Mlynarski W; Sieradzki J
    Diabetes Res Clin Pract; 2003 Nov; 62(2):105-11. PubMed ID: 14581147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension.
    Rodríguez-Esparragón FJ; Rodríguez-Pérez JC; Macías-Reyes A; Alamo-Santana F
    J Hypertens; 2003 Sep; 21(9):1649-55. PubMed ID: 12923396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
    Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
    J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.
    Vänttinen M; Nuutila P; Pihlajamäki J; Hällsten K; Virtanen KA; Lautamäki R; Peltoniemi P; Kemppainen J; Takala T; Viljanen AP; Knuuti J; Laakso M
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4249-54. PubMed ID: 15855261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
    Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
    Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
    Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
    Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
    Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
    Wang C; Zhai F; Chi Y; Wang G
    Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.
    Pihlajamäki J; Vanhala M; Vanhala P; Laakso M
    Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
    Deeb SS; Fajas L; Nemoto M; Pihlajamäki J; Mykkänen L; Kuusisto J; Laakso M; Fujimoto W; Auwerx J
    Nat Genet; 1998 Nov; 20(3):284-7. PubMed ID: 9806549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
    Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
    J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.